Prospective 6-month, double-blind trial of hydroxychloroquine treatment of CPDD

Compr Ther. 1997 May;23(5):327-31.
No abstract available

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Antirheumatic Agents / therapeutic use*
  • Chondrocalcinosis / drug therapy*
  • Double-Blind Method
  • Female
  • Humans
  • Hydroxychloroquine / therapeutic use*
  • Male
  • Middle Aged
  • Prospective Studies

Substances

  • Antirheumatic Agents
  • Hydroxychloroquine